Antitumor effects of an antibody-carboxypeptidase g2 conjugate in combination with a benzoic acid mustard prodrug D. C. BlakeyB. E. ValcacciaK. D. Bagshawe OriginalPaper Pages: 1 - 8
Identification of prodrug, active drug, and metabolites in an ADEPT clinical study C. J. SpringerG. K. PoonK. D. Bagshawe OriginalPaper Pages: 9 - 26
Monoclonal antibodies for intravesical radioimmunotherapy of human bladder cancer P. J. RussellJ. PlomleyN. Pearce OriginalPaper Pages: 27 - 47
Technetium-99m-labeled antibodies C. S. R. GoodenD. E. SnookAgamemnon A. Epenetos OriginalPaper Pages: 49 - 59
A recombinant single-chain antibody interleukin-2 fusion protein Philip SavageAlex SoAgamemnon A. Epenetos OriginalPaper Pages: 61 - 77
Membrane-bound and soluble IL-2 receptors (p55 and p75 chains) on peripheral blood mononuclear cells from patients with solid malignancies Giovanni MantovaniAntonio MacciòG. Sergio Del Giacco OriginalPaper Pages: 79 - 99
pS2—A new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancer M. CorrealeI. AbbateM. De Lena OriginalPaper Pages: 101 - 110
Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer C. J. DeanS. A. EcclesJ. Styles OriginalPaper Pages: 111 - 127
Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor H. ModjtahediS. A. EcclesC. J. Dean OriginalPaper Pages: 129 - 146
Monoclonal antibodies for the treatment of metastases S. A. EcclesG. BoxC. J. Dean OriginalPaper Pages: 165 - 187
Antigen recognition and targeted delivery by the single-chain Fv James S. HustonMei-Sheng TaiHermann Oppermann OriginalPaper Pages: 189 - 224
A universal antibody-derived targeting agent Robert A. SpoonerMahendra P. DeonarainAgamemnon A. Epenetos OriginalPaper Pages: 225 - 242